MMP2 and neoplasm: Inhibition of MMP2/9 significantly increased the CD8+ T cell cytotoxicity and ability to eliminate tumor cells (Fig. 1f, g), and the CD8+ T cell cytotoxicity and killing ability was significantly stronger with IFNγ induction, which induced PD-L1 surface expression [38].